Natco Pharma Plunges 11% As Company Receives 483 US FDA Observations
Shares in Natco Pharma plunged as much as 11 per cent, after the company said that it has received 483 observations from the US FDA. The stock of Natco Pharma last trading at Rs 417, down 11.1 per cent in trade. ...